AYR Wellness

What it is

AYR Wellness Inc. is a vertically integrated cannabis company that operates cultivation facilities, manufacturing sites, and retail dispensaries across multiple US state-legal markets. It is publicly traded on the Canadian Securities Exchange under the symbol AYR.A and on US OTC markets as AYRWF ^[1][2]. The company is headquartered in Miami, Florida ^[1].

AYR was originally formed through a 2019 capital-pool transaction that combined several state-licensed cannabis operators under a single holding company then known as Ayr Strategies, later renamed Ayr Wellness ^[2][3]. Like other US MSOs, AYR cannot list on major US exchanges because cannabis remains federally illegal in the United States ^[4].

Ownership and corporate structure

AYR Wellness is a publicly held corporation rather than a subsidiary of a larger parent. Its shares are widely held and trade on the CSE and OTC markets ^[1][2]. The company files continuous disclosure documents on SEDAR+ (Canada) and reports to US securities regulators through its OTC listing ^[2][5].

Leadership has changed multiple times since 2019. Founder Jonathan Sandelman stepped down as CEO in 2023, and the company has since announced further executive transitions as part of a broader restructuring ^[5][6]. Readers should consult AYR's latest annual filing for current officers, directors, and any material changes in control.

Market and category focus

AYR operates as a vertically integrated cannabis operator, meaning it cultivates, processes, and sells its own products through its own dispensaries in most of its markets. The company has reported operations in states including Florida, Pennsylvania, Massachusetts, New Jersey, Ohio, Nevada, Illinois, and Connecticut, with its retail footprint concentrated under the Liberty Health Sciences banner in Florida and various banners in other states ^[1][5]. The exact list of active stores and licenses changes over time as AYR has divested some assets and closed others during restructuring ^[6][7]; the current state-by-state footprint should be checked against AYR's most recent investor materials.

AYR's product categories span flower, pre-rolls, vape cartridges, concentrates, and edibles, sold both in medical-only and adult-use markets depending on state law.

House brands

AYR markets several in-house product lines, including:

• Kynd — flower and pre-rolls, originally a Nevada brand AYR acquired and rolled out to additional states ^[1].
• Origyn — extracts and concentrates ^[1].
• STIX — pre-rolls ^[1].
• Lazarus Naturals is not an AYR brand; it is a separate Oregon-based hemp CBD company. AYR's similarly named Lazarus cannabis line is distinct. Confirm which product you are looking at before assuming any connection.

This profile does not endorse any of these products. Cannabinoid content, terpene profile, cultivar genetics, and pesticide/heavy-metal testing vary by batch and by state. The only reliable check is the certificate of analysis (COA) for the specific package in front of you Strong evidence.

Reputation, awards, and controversies

AYR brands have won occasional state-level cannabis cup or industry awards, but cannabis competitions vary widely in rigor and are not a reliable proxy for quality or safety Weak / limited. Treat trophy claims on packaging with skepticism unless you can verify the competition and category.

Financially, AYR has had a difficult run. Reuters, MJBizDaily, and other trade outlets have reported on the company's substantial debt load, sharp share-price decline since its 2021 peak, asset sales, and ongoing debt-restructuring negotiations with noteholders ^[6][7]. In 2024 AYR announced amendments to senior secured debt and warned about going-concern risks in regulatory filings ^[5][6]. None of this is unique to AYR — most US MSOs have struggled with falling wholesale prices and IRS Section 280E tax burdens ^[4] — but it is material context for anyone evaluating the company as an investor, supplier, or employee.

This profile is not aware of any major product-safety recall uniquely tied to AYR at the time of writing, but state cannabis recalls happen regularly across the industry; check your state regulator's recall list for current information.

Availability and legal status

AYR products are sold only inside state-legal cannabis markets where AYR or its subsidiaries hold licenses. Cannabis remains a Schedule I controlled substance under US federal law as of this writing, and interstate shipment of THC products is illegal regardless of state law ^[4]. There is no legal direct-to-consumer mail order of AYR's THC cannabis products. Any website claiming to ship AYR THC flower, vapes, or edibles across state lines should be treated as either illegal or fraudulent.

What to verify before relying on brand claims

Before treating any claim about AYR — by AYR, by a retailer, or by this article — as current, check:

1. Current licensing in your state via the state cannabis regulator's public license lookup.
2. Corporate status and filings on SEDAR+ and the company's investor relations page ^[2][5].
3. The COA for the specific batch of product, ideally with cannabinoid and contaminant results from an ISO-accredited lab.
4. Recent news on restructuring, ownership changes, or store closures, which have been frequent in the MSO sector ^[6][7].
5. Whether "Lazarus" on a package refers to AYR's cannabis line or to the unrelated Lazarus Naturals hemp CBD brand.

This profile was last checked in 2025. Brand portfolios, store counts, and corporate structure in the US cannabis industry change frequently; nothing here should be treated as a substitute for primary regulatory filings or current state license records.

Sources

How this page was made